1222 IN VITRO RESISTANCE TO ALS-2200, A POTENT NUCLEOTIDE POLYMERASE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS C
Tan, H, Jekle, A, Kang, H, Moy, C, Deval, J, Tigges, A, Zhang, E, Jiang, M, Andzinski, A, Dyatkina, N, Wang, G, Rijnbrand, R, Kieffer, T.L, Blatt, L.M, Beigelman, L, Smith, D.B, Symons, J.A
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
1150 A COMPREHENSIVE REVIEW OF PATTERNS OF VIRAL LOAD DECLINE IN PATIENTS TREATED WITH TELAPREVIR PLUS PEGINTERFERON AND RIBAVIRIN
Picchio, G, De Meyer, S, Dierynck, I, Ghys, A, Gritz, L, Kieffer, T.L, Bartels, D.J, Tomaka, F, Bengtsson, L, Luo, D, Jacobson, I.M, Kauffman, R.S, Adda, N, Sarrazin, C
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
55 FUTILITY RULES IN TELAPREVIR COMBINATION TREATMENT
Jacobson, I.M, Bartels, D.J, Gritz, L, Kieffer, T.L, De Meyer, S, Tomaka, F, Bengtsson, L, Luo, D, Adiwijaya, B.S, Kauffman, R.S, Picchio, G, Adda, N
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY
Zhang, E.Z, Tigges, A, Jiang, M, Dorrian, J, Spanks, J, Ardzinski, A, Alves, K, De Souza, C, Bartels, D.J, Koziel, M.J, Bisceglie, A.M. Di, Kieffer, T.L
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
8 EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS
Sullivan, J.C, De Meyer, S, Bartels, D.J, Dierynck, I, Zhang, E, Spanks, J, Tigges, A, Adda, N, Martin, E.C, Beumont, M, Jacobson, I.M, Sherman, K.E, Zeuzem, S, Picchio, G, Kieffer, T.L
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
1363 VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS
Di Bisceglie, A.M, Nelson, D.R, Gane, E, Alves, K, Koziel, M.J, De Souza, C, Kieffer, T.L, George, S, Kauffman, R.S, Jacobson, I.M, Sulkowski, M.S
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
1202 CHARACTERISATION OF HCV VARIANTS IN NON-SVR PATIENTS IN THE REALIZE STUDY SUGGESTS THAT TELAPREVIR EXHIBITS A CONSISTENT RESISTANCE PROFILE IRRESPECTIVE OF A LEAD-IN
De Meyer, S, Dierynck, I, Ghys, A, Beumont, M, Daems, B, Van Baelen, B, Sullivan, J.C, Kieffer, T.L, Zeuzem, S, Picchio, G
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
1242 LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS C INFECTED PATIENTS TREATED WITH TELAPREVIR: EVALUATION OF PERSISTENCE OF RESISTANT VARIANTS BY ULTRA-DEEP SEQUENCING
Thomas, X.V, de Bruijne, J, Kieffer, T.L, Sullivan, J.C, Rebers, S.P, de Vries, M, Reesink, H.W, Weegink, C.J, Molenkamp, R, Schinkel, J
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219)
Picchio, G, Sarrazin, C, Reesink, H.W, Zeuzem, S, Weegink, C.J, Luo, D, Witek, J, Kieffer, T.L, Bartels, D, Dierynck, I, De Meyer, S
Published in Digestive and liver disease (01.02.2012)
Published in Digestive and liver disease (01.02.2012)
Get full text
Journal Article
T-26 Long-term FU of patients with CHC treated with telaprevir in combination with PEG-IFN alfa-2a and RBV: Interim analysis of the EXTEND study
Alberti, A, Zeuzem, S, Sulkowski, M.S, Zoulim, F, Sherman, K.E, Wei, L.J, van Baelen, B, Sullivan, J, Kieffer, T.L, De Meyer, S, Picchio, G, Tomaka, F, Graham, C, McHutchison, J.G
Published in Digestive and liver disease (2011)
Published in Digestive and liver disease (2011)
Get full text
Journal Article
843 NATURAL PREVALENCE OF HCV VARIANTS WITH DECREASED SUSCEPTIBILITY TO NS3-4A PROTEASE INHIBITORS IN TREATMENT-NAIVE SUBJECTS
Bartels, D.J, Zhou, Y, Zhang, E, Marcial, M, Byrn, R.A, Adiwijaya, B, Lin, C, Kwong, A.D, Kieffer, T.L
Published in Journal of hepatology (2008)
Published in Journal of hepatology (2008)
Get full text
Journal Article
400 MODELING, CLINICAL AND VIROLOGY DATA FROM PHASE 2 AND 3 STUDIES SUPPORT 12-WEEK TELAPREVIR DURATION IN COMBINATION WITH 24- OR 48-WEEK PEGINTERFERON/RIBAVIRIN DURATION
Adiwijaya, B, Kieffer, T.L, Bartels, D.J, Picchio, G, De Meyer, S, Eisenhauer, K, Beumont, M, Adda, N, Wright, C.I, Kauffman, R.S, Garg, V
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article